Xylos Corporation

Xylos Corporation

Other, 6893 Sladek Rd, New Hope, Pennsylvania, 18938, United States, 11-50 Employees

xyloscorp.com

  • LinkedIn

Who is XYLOS CORPORATION

Xylos Corporation is a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. Our proprietary biocellulose technology...

Read More

map
  • 6893 Sladek Rd, New Hope, Pennsylvania, 18938, United States Headquarters: 6893 Sladek Rd, New Hope, Pennsylvania, 18938, United States
  • 11-50 Employees: 11-50
  • dollar-icon Revenue: Under $1 Million

industries-icon Industry: Other

checked-icon Does something look wrong? Fix it. | View contact records from XYLOS CORPORATION

Xylos Corporation Org Chart and Mapping

Employees

Rick Wright

Director, Product Development & Marketing

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding Xylos Corporation

Answer: Xylos Corporation's headquarters are located at 6893 Sladek Rd, New Hope, Pennsylvania, 18938, United States

Answer: Xylos Corporation's official website is https://xyloscorp.com

Answer: Xylos Corporation's revenue is Under $1 Million

Answer: Xylos Corporation has 11-50 employees

Answer: Xylos Corporation is in Other

Answer: Xylos Corporation contact info: Phone number: Website: https://xyloscorp.com

Answer: Xylos Corporation is a medical device company that offers superior biomaterial solutions for the treatment, repair and replacement of human tissue. Our proprietary biocellulose technology possesses the effectiveness, versatility and safety profile to address a broad range of medical applications including surgical implants for musculoskeletal, urological / gynecological, abdominal, cardiovascular, oral / maxillofacial and plastic / aesthetics indications representing an aggregate market opportunity of $4 billion. Additionally, our biomaterial has unique drug delivery properties that have been demonstrated via in vitro and clinical evaluations. To focus our efforts and resources, we are concentrating on the development of select surgical implants for the musculoskeletal field, targeting a U.S. market opportunity of $1 billion.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access